Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centogene AG - |
RCV002284074 | SCV002573481 | pathogenic | Niemann-Pick disease, type C1 | 2022-08-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002284074 | SCV002601895 | likely pathogenic | Niemann-Pick disease, type C1 | 2022-03-09 | criteria provided, single submitter | clinical testing | NM_000271.4(NPC1):c.2146C>T(Q716*) is expected to be pathogenic in the context of Niemann-Pick disease type C1. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in NPC1, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening. |